Actively Recruiting
A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Pediatric Diseases
Led by Ruijin Hospital · Updated on 2024-11-29
35
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
The trial investigates a new approach to PET/MR imaging for children suspected of malignant tumors. It focuses on making PET/MR scans faster, quieter, and more comfortable while using half the usual dose of radioactive tracer. The study explores the use of advanced technologies like flexible coils, silent scanning sequences, and deep learning-based image reconstruction to improve imaging for pediatric patients. Pediatric patients who show clinical symptoms and require 18F-FDG PET/MR scans to clarify their condition are included. The study tests this novel imaging solution in children aged 0 to 18 years. The goal is to demonstrate that this rapid, silent, and lower-dose PET/MR examination is feasible and effective for pediatric use. Participants will undergo PET/MR imaging, and researchers will assess several outcomes over one year, including lesion detection rates, completion rates of PET/MR exams, sedation requirements during scans, and the quality of the images obtained. The study involves cooperation throughout the entire research process to ensure reliable results and aims to improve the scanning experience and diagnostic accuracy in children.
CONDITIONS
Brief Title
A Fast, Quiet, Artificial Intelligence-based PET/MR Solution for Paediatric Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children suspected of malignant tumors by a clinical pediatrician requiring 18F-FDG PET/MR examination
- Signed and dated informed consent form
- Willing to comply and cooperate with all study procedures
- Aged 0 to 18 years, any gender
You will not qualify if you...
- Serious illnesses unsuitable for the study such as severe heart or lung failure, severe bone marrow suppression, severe liver or kidney dysfunction
- Severe claustrophobia, epileptic seizures, respiratory distress preventing lying down, or inability to cooperate due to mental disorders
- Presence of metal implants like pacemakers, artificial heart valves, or neurostimulators
- Non-compliance with study procedures or requirements
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 1 year
Participants undergo 18F-FDG PET/MR imaging using a fast, quiet, artificial intelligence-based solution to clarify their medical condition.
PET/MR examinations as clinically indicated
Duration - Up to 1 year
Participants are monitored over time to assess lesion detection, image quality, and sedation during PET/MR examinations.
Follow-up visits as needed based on clinical care
Trial Site Locations
Total: 1 location
1
China, Shanghai Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine
Shanghai, Shanghai Municipality, China, 200001
Actively Recruiting
Research Team
J
Jiajia Hu
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here